JAHEN(SZ:300955) Xin Lang Zheng Quan·2025-09-12 09:09Core Insights - The skincare and daily chemical industry in A-share has shown significant performance divergence among 14 representative listed companies in the first half of 2025, with 6 companies experiencing both revenue and profit declines, 6 companies achieving double growth, 1 company increasing revenue but not profit, and 1 company reporting a loss [1][2]. Performance Summary - Companies with Double Growth: 6 companies achieved both revenue and profit growth, although specific names and figures are not provided in the documents. - Companies with Double Decline: - Lafang Cosmetics: Revenue of 410 million yuan, down 4.27%, net profit of 6 million yuan, down 82.89% [2]. - Furuida: Revenue of 1.79 billion yuan, down 7.05%, net profit of 108 million yuan, down 15.16% [2]. - Fulejia: Revenue of 863 million yuan, down 8.15%, net profit of 230 million yuan, down 32.54% [2]. - Beitaini: Revenue of 2.372 billion yuan, down 15.43%, net profit of 247 million yuan, down 49.01% [2]. - Huaxi Biological: Revenue of 2.261 billion yuan, down 19.57%, net profit of 221 million yuan, down 35.38% [2]. - Kesi Co.: Revenue of 721 million yuan, down 48.67%, net profit of 65 million yuan, down 84.51% [2]. - Company with Increased Revenue but Decreased Profit: Chuang'er Biological achieved revenue of 214 million yuan, up 16.98%, but net profit decreased to 13 million yuan, down 55.99% [3][4]. - Company Reporting a Loss: Jiaheng Cosmetics reported revenue of 514 million yuan, up 21.72%, but a net loss of 32 million yuan, with losses expanding significantly [5][6]. The loss is attributed to increased operational costs and fixed expenses related to its Huzhou base [5]. Industry Challenges - Lafang Cosmetics cited increased market pressures and intensified competition as reasons for its significant profit decline, despite higher sales and financial expenses [6].